Samir El Andaloussi
Professor
E-postadress: samir.el-andaloussi@ki.se
Telefon: +46852483571
Mobiltelefon: +46737121613
Besöksadress: Hälsovägen 7, Novum plan 5, 14157
Postadress: H5 Laboratoriemedicin, H5 BCM El Andaloussi, 141 52 Huddinge
Del av:
- Institutionen för laboratoriemedicin
- Avdelningen för biomolekylär och cellulär medicin (BCM)
- Biomolekylär medicin och avancerade terapier- fokus på leverans av RNA-baserade läkemedel – Samir EL Andaloussis forskargrupp
Om mig
- Samir EL Andaloussi är professor i biomolekylär medicin och avancerad terapi vid Karolinska Institutet sedan 1 november 2021.
Han har en examen i molekylär cellbiologi från Södertörns högskola 2002 och disputerade vid Stockholms universitet 2008. Han har gjort postdocs vid Stockholms universitet 2008–2010, KI:s institution för laboratoriemedicin, LabMed, 2010–2012, samt University of Oxford, Storbritannien, 2011–2013. I Oxford var han även research fellow 2013–2018.
Sedan 2013 forskar EL Andaloussi åter vid KI. Han blev docent 2018 och biträdande chef för avdelning för biomolekylär och cellulär medicin vid institutionen för laboratoriemedicin 2021.
Artiklar
- Article: MOLECULAR THERAPY NUCLEIC ACIDS. 2025;36(2):102522Estupinan HY; Baladi T; Roudi S; Munson MJ; Bost J; Gustafsson O; Velasquez-Ramirez D; Bhatt DK; Hagey D; Hekman D; Andersson S; El Andaloussi S; Dahlen A
- Article: JOURNAL OF CONTROLLED RELEASE. 2025;382:113665Offens A; Teeuwen L; Akpinar GG; Steiner L; Kooijmans S; Mamand D; Weissinger H; Kall A; Eldh M; Wiklander OPB; El-Andaloussi S; Karlsson MCI; Vader P; Gabrielsson S
- Journal article: NATURE REVIEWS BIOENGINEERING. 2025;3(6):505-520Zheng W; Roudi S; Zhou H; Lara Corona M; van Niel G; Nordin JZ; EL Andaloussi S
- Article: RSC CHEMICAL BIOLOGY. 2025;6(5):761-771Bestas B; Estupinan HY; Wang Q; Kharazi S; He C; K. Mohammad D; Gupta D; Wiklander OPB; Lehto T; Lundin KE; Berglof A; Karlsson MCI; Abendroth F; El Andaloussi S; Gait MJ; Wood MJA; Leumann CJ; Stetsenko DA; Mansson R; Wengel J; Zain R; Smith CIE
- Article: NATURE COMMUNICATIONS. 2025;16(1):4028Liang X; Gupta D; Xie J; Van Wonterghem E; Van Hoecke L; Hean J; Niu Z; Ghaeidamini M; Wiklander OPB; Zheng W; Wiklander RJ; He R; Mamand DR; Bost J; Zhou G; Zhou H; Roudi S; Estupinan HY; Radler J; Zickler AM; Gorgens A; Hou VWQ; Slovak R; Hagey DW; de Jong OG; Uy AG; Zong Y; Mager I; Perez CM; Roberts TC; Carter D; Vader P; Esbjorner EK; de Fougerolles A; Wood MJA; Vandenbroucke RE; Nordin JZ; EL Andaloussi S
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2025;122(16):e2414174122Stridfeldt F; Pandey V; Kylhammar H; Gevari MT; Metem P; Agrawal V; Goergens A; Mamand DR; Gilbert J; Palmgren L; Holme MN; Gustafsson O; El Andaloussi S; Mitra D; Dev A
- Article: ADVANCED MATERIALS. 2025;37(17):e2419538Ojansivu M; Barriga HMG; Holme MN; Morf S; Doutch JJ; Andaloussi SEL; Kjellman T; Johnsson M; Barauskas J; Stevens MM
- Article: HUMAN REPRODUCTION OPEN. 2025;2025(2):hoaf010Apostolov A; Mladenovic D; Tilk K; Lohmus A; Baev V; Yahubyan G; Sola-Leyva A; Bergamelli M; Goergens A; Zhao C; Andaloussi SEL; Kalinina A; Acharya G; Lanner F; Saare M; Peters M; Piomboni P; Luddi A; Salumets A; Aleksejeva E
- Article: NANO LETTERS. 2025;25(6):2173-2180Sych T; Gorgens A; Steiner L; Gucluler G; Huge Y; Alamdari F; Johansson M; Aljabery F; Sherif A; Gabrielsson S; El Andaloussi S; Sezgin E
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2025;14(2):e70042Singh B; Fredriksson Sundbom M; Muthukrishnan U; Natarajan B; Stransky S; Gorgens A; Nordin JZ; Wiklander OPB; Sandblad L; Sidoli S; El Andaloussi S; Haney M; Gilthorpe JD
- Article: NUCLEIC ACIDS RESEARCH. 2025;53(2):gkaf016Garcia-Guerra A; Sathyaprakash C; de Jong OG; Lim WF; Vader P; El Andaloussi S; Bath J; Reine J; Aoki Y; Turberfield AJ; Wood MJA; Rinaldi C
- Article: EXTRACELLULAR VESICLE. 2024;4:100054Martin Perez C; Liang X; Gupta D; Haughton ER; Conceição M; Mäger I; El Andaloussi S; Wood MJA; Roberts TC
- Article: ACS CHEMICAL NEUROSCIENCE. 2024;15(22):4095-4104Christ W; Kapell S; Sobkowiak MJ; Mermelekas G; Evertsson B; Sork H; Saher O; Bazaz S; Gustafsson O; Cardenas EI; Villa V; Ricciarelli R; Sandberg JK; Bergquist J; Sturchio A; Svenningsson P; Malm T; Espay AJ; Pernemalm M; Lindeen A; Klingstrom J; El Andaloussi S; Ezzat K
- Article: NATURE BIOMEDICAL ENGINEERING. 2024;8(11):1453-1468Wiklander OPB; Mamand DR; Mohammad DK; Zheng W; Jawad Wiklander R; Sych T; Zickler AM; Liang X; Sharma H; Lavado A; Bost J; Roudi S; Corso G; Lennaard AJ; Abedi-Valugerdi M; Maeger I; Alici E; Sezgin E; Nordin JZ; Gupta D; Goergens A; EL Andaloussi S
- Article: ADVANCED SCIENCE. 2024;11(42):e2407619Zickler AM; Liang X; Gupta D; Mamand DR; De Luca M; Corso G; Errichelli L; Hean J; Sen T; Elsharkasy OM; Kamei N; Niu Z; Zhou G; Zhou H; Roudi S; Wiklander OPB; Gorgens A; Nordin JZ; Castilla-Llorente V; EL Andaloussi S
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2024;13(10):e12523Bobbili MR; Goergens A; Yan Y; Vogt S; Gupta D; Corso G; Barbaria S; Patrioli C; Weilner S; Pultar M; Jacak J; Hackl M; Schosserer M; Grillari R; Kjems J; Andaloussi SEL; Grillari J
- Article: JOURNAL OF PROTEOME RESEARCH. 2024;23(9):4114-4127Sharma N; Angori S; Sandberg A; Mermelekas G; Lehtio J; Wiklander OPB; Gorgens A; El Andaloussi S; Eriksson H; Pernemalm M
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2024;13(7):e12471Mamand DR; Bazaz S; Mohammad DK; Liang X; Pavlova S; Mim C; Gabrielsson S; Nordin JZ; Wiklander OPB; Abedi-Valugerdi M; EL-Andaloussi S
- Journal article: CYTOTHERAPY. 2024;26(6):s90Yan D; Haughton E; Liang X; El Andaloussi S; Wood M; Gupta D
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2024;13(6):e12463Nguyen VVT; Welsh JA; Tertel T; Choo A; van de Wakker SI; Defourny KAY; Giebel B; Vader P; Padmanabhan J; Lim SK; Nolte-'t Hoen ENM; Verhaar MC; Bostancioglu RB; Zickler AM; Hong JM; Jones JC; EL Andaloussi S; van Balkom BWM; Goergens A
- Article: NATURE BIOTECHNOLOGY. 2024;42(4):587-590Sych T; Schlegel J; Barriga HMG; Ojansivu M; Hanke L; Weber F; Bostancioglu RB; Ezzat K; Stangl H; Plochberger B; Laurencikiene J; El Andaloussi S; Fuerth D; Stevens MM; Sezgin E
- Article: NATURE MICROBIOLOGY. 2024;9(4):905-921Gross R; Ressin H; von Maltitz P; Albers D; Schneider L; Bley H; Hoffmann M; Cortese M; Gupta D; Deniz M; Choi J-Y; Jansen J; Preusser C; Seehafer K; Poehlmann S; Voelker DR; Goffinet C; Pogge-von Strandmann E; Bunz U; Bartenschlager R; El Andaloussi S; Sparrer KMJ; Herker E; Becker S; Kirchhoff F; Muench J; Mueller JA
- Article: STEM CELL RESEARCH & THERAPY. 2024;15(1):77Gencer EB; Lor YK; Abomaray F; El Andaloussi S; Pernemalm M; Sharma N; Hagey DW; Gorgens A; Gustafsson MO; Le Blanc K; Toonsi MA; Walther-Jallow L; Goetherstrom C
- Article: INTERNATIONAL IMMUNOPHARMACOLOGY. 2024;129:111584Mamand DR; Bazaz S; Mohammad DK; Saher O; Wiklander OPB; Sadeghi B; Hassan M; EL-Andaloussi S; Abedi-Valugerdi M
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2024;13(1):e12396van de Wakker SI; Bauza-Martinez J; Rios Arceo C; Manjikian H; Snijders Blok CJB; Roefs MT; Willms E; Maas RGC; Pronker MF; de Jong OG; Wu W; Goergens A; El Andaloussi S; Sluijter JPG; Vader P
- Article: CELLS. 2023;12(18):2285Gupta D; Orehek S; Turunen J; O'Donovan L; Gait MJ; El-Andaloussi S; Wood MJA
- Article: MOLECULAR THERAPY NUCLEIC ACIDS. 2023;33:511-528Hanson B; Vorobieva I; Zheng W; Conceicao M; Lomonosova Y; Mager I; Puri PL; El Andaloussi S; Wood MJA; Roberts TC
- Article: HAEMATOLOGICA. 2023;108(9):2422-2434Hagey DW; Kvedaraite E; Akber M; Goergens A; Javadi J; Greenwood TVB; Bjorklund C; Akefeldt SO; Hannegard-Hamrin T; Arnell H; Dobra K; Herold N; Svensson M; El Andaloussi S; Henter J-I; Lourda M
- Article: SCIENCE ADVANCES. 2023;9(35):eadh1168Hagey DW; Ojansivu M; Bostancioglu BR; Saher O; Bost JP; Gustafsson MO; Gramignoli R; Svahn M; Gupta D; Stevens MM; Goergens A; EL Andaloussi S
- Article: SCIENTIFIC REPORTS. 2023;13(1):13589Juul N; Willacy O; Mamand DR; El Andaloussi S; Eisfeldt J; Chamorro CI; Fossum M
- Article: NATURE COMMUNICATIONS. 2023;14(1):4734Zheng W; Raedler J; Sork H; Niu Z; Roudi S; Bost JPP; Goergens A; Zhao Y; Mamand DRR; Liang X; Wiklander OPB; Lehto T; Gupta D; Nordin JZZ; EL Andaloussi S
- Article: CYTOTHERAPY. 2023;25(8):810-814Toh WS; Yarani R; El Andaloussi S; Cho BS; Choi C; Corteling R; De Fougerolles A; Gimona M; Herz J; Khoury M; Robbins PD; Williams D; Weiss DJ; Rohde E; Giebel B; Lim SK
- Article: CELL DEATH DISCOVERY. 2023;9(1):260Li C; Sun C; Lohcharoenkal W; Ali MM; Xing P; Zheng W; Gorgens A; Gustafsson MO; EL Andaloussi S; Sonkoly E; Pivarcsi A
- Article: JOURNAL OF CONTROLLED RELEASE. 2023;357:630-640Zheng W; Schuerz M; Wiklander RJ; Gustafsson O; Gupta D; Slovak R; Traista A; Coluzzi A; Roudi S; Barone A; Farcas D; Kyriakopoulou E; Galli V; Sharma H; Meisner-Kober N; Honcharenko M; Andaloussi SEL
- Article: LEUKEMIA. 2023;37(4):888-900Boberg E; Kadri N; Hagey DWW; Schwieler L; El Andaloussi S; Erhardt S; Iacobaeus E; Le Blanc K
- Article: NANOSCALE ADVANCES. 2023;5(6):1691-1705Li L; Mussack V; Goergens A; Pepeldjiyska E; Hartz AS; Aslan H; Rackl E; Rank A; Schmohl J; El Andaloussi S; Pfaffl MW; Schmetzer H
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2023;12(2):e12306Xie J; Cools L; Van Imschoot G; Van Wonterghem E; Pauwels MJ; Vlaeminck I; De Witte C; EL Andaloussi S; Wierda K; De Groef L; Haesebrouck F; Van Hoecke L; Vandenbroucke RE
- Article: SCIENCE IMMUNOLOGY. 2022;7(78):eadd3330Kvedaraite E; Milne P; Khalilnezhad A; Chevrier M; Sethi R; Lee HK; Hagey DW; Greenwood TVB; Mouratidou N; Jadersten M; Lee NYS; Minnerup L; Tan Y; Dutertre C-A; Benac N; Hwang YY; Lum J; Loh AHP; Jansson J; Teng KWW; Khalilnezhad S; Xu W; Resteu A; Tey HL; Guan NL; Larbi A; Howland SW; Arnell H; Andaloussi SEL; Braier J; Rassidakis G; Galluzzo L; Dzionek A; Henter J-I; Chen J; Collin M; Ginhoux F
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2022;11(12):e12290Zheng W; He R; Liang X; Roudi S; Bost J; Pierre-Michael C; van Niel G; Andaloussi SEL
- Article: BIOMATERIALS. 2022;290:121830Pauwels MJ; Xie J; Ceroi A; Balusu S; Castelein J; Van Wonterghem E; Van Imschoot G; Ward A; Menheniott TR; Gustafsson O; Combes F; El Andaloussi S; Sanders NN; Mager I; Van Hoecke L; Vandenbroucke RE
- Article: CANCER GENE THERAPY. 2022;29(11):1600-1615Li L; Gorgens A; Mussack V; Pepeldjiyska E; Hartz AS; Rank A; Schmohl J; Kra''mer D; Andaloussi SE; Pfaffl MW; Schmetzer H
- Article: JOURNAL OF ALZHEIMERS DISEASE. 2022;90(1):333-348Sturchio A; Dwivedi AK; Malm T; Wood MJA; Cilia R; Sharma JS; Hill EJ; Schneider LS; Graff-Radford NR; Mori H; Nuebling G; El Andaloussi S; Svenningsson P; Ezzat K; Espay AJ
- Journal article: 2022Li C; Sun C; Elton J; Lohcharoenkal W; Sonkoly E; Pivarcsi A; Görgens A; El Andaloussi S
- Article: MOLECULAR THERAPY. 2022;30(9):3078-3094Bevers S; Kooijmans SAA; Van de Velde E; Evers MJW; Seghers S; Gitz-Francois JJJM; van Kronenburg NCH; Fens MHAM; Mastrobattista E; Hassler L; Sork H; Lehto T; Ahmed KE; El Andaloussi S; Fiedler K; Breckpot K; Maes M; Van Hoorick D; Bastogne T; Schiffelers RM; De Koker S
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2022;11(7):e12248Liang X; Niu Z; Galli V; Howe N; Zhao Y; Wiklander OPB; Zheng W; Wiklander RJ; Corso G; Davies C; Hean J; Kyriakopoulou E; Mamand DR; Amin R; Nordin JZ; Gupta D; Andaloussi SEL
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2022;11(6):e12238Gorgens A; Corso G; Hagey DW; Wiklander RJ; Gustafsson MO; Felldin U; Lee Y; Bostancioglu RB; Sork H; Liang X; Zheng W; Mohammad DK; van DWSI; Vader P; Zickler AM; Mamand DR; Ma L; Holme MN; Stevens MM; Wiklander OPB; El Andaloussi S
- Article: NANOSCALE. 2022;14(12):4690-4704Minelli C; Wywijas M; Bartczak D; Cuello-Nunez S; Infante HG; Deumer J; Gollwitzer C; Krumrey M; Murphy KE; Johnson ME; Bustos ARM; Strenge IH; Faure B; Hoghoj P; Tong V; Burr L; Norling K; Hook F; Roesslein M; Kocic J; Hendriks L; Kestens V; Ramaye Y; Lopez MCC; Auclair G; Mehn D; Gilliland D; Potthoff A; Oelschlagel K; Tentschert J; Jungnickel H; Krause BC; Hachenberger YU; Reichardt P; Luch A; Whittaker TE; Stevens MM; Gupta S; Singh A; Lin F-H; Liu Y-H; Costa AL; Baldisserri C; Jawad R; Andaloussi SEL; Holme MN; Lee TG; Kwak M; Kim J; Ziebel J; Guignard C; Cambier S; Contal S; Gutleb AC; Tatarkiewicz JK; Jankiewicz BJ; Bartosewicz B; Wu X; Fagan JA; Elje E; Runden-Pran E; Dusinska M; Kaur IP; Price D; Nesbitt I; O'Reilly S; Peters RJB; Bucher G; Coleman D; Harrison AJ; Ghanem A; Gering A; McCarron E; Fitzgerald N; Cornelis G; Tuoriniemi J; Sakai M; Tsuchida H; Maguire C; Prina-Mello A; Lawlor AJ; Adams J; Schultz CL; Constantin D; Nguyen TKT; Le DT; Panariello L; Damilos S; Gavriilidis A; Lynch I; Fryer B; Quevedo AC; Guggenheim E; Briffa S; Valsami-Jones E; Huang Y; Keller AA; Kinnunen V-T; Peramaki S; Krpetic Z; Greenwood M; Shard AG
- Article: ADVANCED HEALTHCARE MATERIALS. 2022;11(5):e2101658Bost JP; Saher O; Hagey D; Mamand DR; Liang X; Zheng W; Corso G; Gustafsson O; Gorgens A; Smith CIE; Zain R; El Andaloussi S; Gupta D
- Article: COMMUNICATIONS BIOLOGY. 2022;5(1):185Bost JP; Ojansivu M; Munson MJ; Wesen E; Gallud A; Gupta D; Gustafsson O; Saher O; Radler J; Higgins SG; Lehto T; Holme MN; Dahlen A; Engkvist O; Stromstedt P-E; Andersson S; Smith CIE; Stevens MM; Esbjorner EK; Collen A; El Andaloussi S
- Article: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2022;170:59-69van DWSI; van Oudheusden J; Mol EA; Roefs MT; Zheng W; Gorgens A; El Andaloussi S; Sluijter JPG; Vader P
- Article: PHARMACEUTICS. 2021;14(1):38Lennaard AJ; Mamand DR; Wiklander RJ; EL Andaloussi S; Wiklander OPB
- Article: NATURE COMMUNICATIONS. 2021;12(1):6666Dar GH; Mendes CC; Kuan W-L; Speciale AA; Conceicao M; Gorgens A; Uliyakina I; Lobo MJ; Lim WF; El Andaloussi S; Mager I; Roberts TC; Barker RA; Goberdhan DCI; Wilson C; Wood MJA
- Article: BIOMOLECULES. 2021;11(11):1606Javadi J; Goergens A; Vanky H; Gupta D; Hjerpe A; EL-Andaloussi S; Hagey D; Dobra K
- Article: FRONTIERS IN PHYSIOLOGY. 2021;12:689179Aoki Y; Rocha CSJ; Lehto T; Miyatake S; Johansson H; Hashimoto Y; Nordin JZ; Mager I; Aoki M; Graham M; Sathyaprakash C; Roberts TC; Wood MJA; Behlke MA; El Andaloussi S
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2021;10(12):e12142Hagey DW; Kordes M; Gorgens A; Mowoe MO; Nordin JZ; Moro CF; Lohr J-M; El Andaloussi S
- Article: NATURE BIOMEDICAL ENGINEERING. 2021;5(9):1084-1098Gupta D; Wiklander OPB; Görgens A; Conceição M; Corso G; Liang X; Seow Y; Balusu S; Feldin U; Bostancioglu B; Jawad R; Mamand DR; Lee YXF; Hean J; Mäger I; Roberts TC; Gustafsson M; Mohammad DK; Sork H; Backlund A; Lundin P; de Fougerolles A; Smith CIE; Wood MJA; Vandenbroucke RE; Nordin JZ; El-Andaloussi S
- Article: BIOMEDICINES. 2021;9(8):1046Bazaz S; Lehto T; Tops R; Gissberg O; Gupta D; Bestas B; Bost J; Wiklander OPB; Sork H; Zaghloul EM; Mamand DR; Hallbrink M; Sillard R; Saher O; Ezzat K; Smith CIE; El Andaloussi S; Lehto T
- Article: ECLINICALMEDICINE. 2021;38:100988Sturchio A; Dwivedi AK; Young CB; Malm T; Marsili L; Sharma JS; Mahajan A; Hill EJ; El Andaloussi S; Poston KL; Manfredsson FP; Schneider LS; Ezzat K; Espay AJ
- Article: CELLS. 2021;10(6):1543Sork H; Conceicao M; Corso G; Nordin J; Lee YXF; Krjutskov K; Orzechowski Westholm J; Vader P; Pauwels M; Vandenbroucke RE; Wood MJA; EL Andaloussi S; Mager I
- Article: PHARMACEUTICS. 2021;13(6):878Gustafsson O; Radler J; Roudi S; Lehto T; Hallbrink M; Lehto T; Gupta D; EL Andaloussi S; Nordin JZ
- Article: ACS APPLIED POLYMER MATERIALS. 2021;3(4):2197-2210Ossipov DA; Gustafsson O; Luchow M; El Andaloussi S; Malkoch M
- Article: SMALL. 2021;17(14):e2008155Cavallaro S; Pevere F; Stridfeldt F; Gorgens A; Paba C; Sahu SS; Mamand DR; Gupta D; El Andaloussi S; Linnros J; Dev A
- Article: PHARMACEUTICS. 2021;13(1):116Daralnakhla H; Saher O; Zamolo S; Bazaz S; P. Bost J; Heitz M; Lundin KE; El Andaloussi S; Darbre T; Reymond J-L; Zain R; Smith CIE
- Article: BIOMATERIALS. 2021;266:120435Conceica M; Forcina L; Wiklander OPB; Gupta D; Nordin JZ; Vrellaku B; McClorey G; Mager I; Gorgens A; Lundin P; Musaro A; Wood MJA; Andaloussi SEL; Roberts TC
- Article: NUCLEIC ACIDS RESEARCH. 2020;48(21):12234-12251Visnes T; Benitez-Buelga C; Cazares-Korner A; Sanjiv K; Hanna BMF; Mortusewicz O; Rajagopal V; Albers JJ; Hagey DW; Bekkhus T; Eshtad S; Baquero JM; Masuyer G; Wallner O; Muller S; Pham T; Gokturk C; Rasti A; Suman S; Torres-Ruiz R; Sarno A; Wiita E; Homan EJ; Karsten S; Marimuthu K; Michel M; Koolmeister T; Scobie M; Loseva O; Almlof I; Unterlass JE; Pettke A; Bostrom J; Pandey M; Gad H; Herr P; Jemth A-S; El Andaloussi S; Kalderen C; Rodriguez-Perales S; Benitez J; Krokan HE; Altun M; Stenmark P; Berglund UW; Helleday T
- Article: MOLECULAR MEDICINE REPORTS. 2020;22(6):4589-4600Fan C; El Andaloussi S; Lehto T; Kong KW; Seow Y
- Article: MOLECULAR & CELLULAR PROTEOMICS. 2020;19(12):2047-2068van Westering TLE; Johansson HJ; Hanson B; Coenen-Stass AML; Lomonosova Y; Tanihata J; Motohashi N; Yokota T; Takeda S; Lehtio J; Wood MJA; EL Andaloussi S; Aoki Y; Roberts TC
- Article: FRONTIERS IN AGING NEUROSCIENCE. 2020;12:553635Sturchio A; Marsili L; Vizcarra JA; Dwivedi AK; Kauffman MA; Duker AP; Lu P; Pauciulo MW; Wissel BD; Hill EJ; Stecher B; Keeling EG; Vagal AS; Wang L; Haslam DB; Robson MJ; Tanner CM; Hagey DW; El Andaloussi S; Ezzat K; Fleming RMT; Lu LJ; Little MA; Espay AJ
- Article: CELLS. 2020;9(9):E2123-2123Morandi F; Marimpietri D; Goergens A; Gallo A; Srinivasan RC; El-Andaloussi S; Gramignoli R
- Article: MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT. 2020;18:880-892Berger E; Colosetti P; Jalabert A; Meugnier E; Wiklander OPB; Jouhet J; Errazurig-Cerda E; Chanon S; Gupta D; Rautureau GJP; Geloen A; El-Andaloussi S; Panthu B; Rieusset J; Rome S
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2020;9(1):1808281Conzelmann C; Gross R; Zou M; Krueger F; Goergens A; Gustafsson MO; El Andaloussi S; Muench J; Mueller JA
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2020;9(1):1800222Gupta D; Liang X; Pavlova S; Wiklander OPB; Corso G; Zhao Y; Saher O; Bost J; Zickler AM; Piffko A; Maire CL; Ricklefs FL; Gustafsson O; Llorente VC; Gustafsson MO; Bostancioglu RB; Mamand DR; Hagey DW; Goergens A; Nordin JZ; EL Andaloussi S
- Article: CYTOMETRY PART B-CLINICAL CYTOMETRY. 2020;97(6):602-609Tertel T; Bremer M; Maire C; Lamszus K; Peine S; Jawad R; Andaloussi SEL; Giebel B; Ricklefs FL; Goergens A
- Article: FRONTIERS IN NEUROSCIENCE. 2020;14:256Malmberg M; Malm T; Gustafsson O; Sturchio A; Graff C; Espay AJ; Wright AP; El Andaloussi S; Linden A; Ezzat K
- Article: NATURE COMMUNICATIONS. 2020;11(1):1113de Jong OG; Murphy DE; Maeger I; Willms E; Garcia-Guerra A; Gitz-Francois JJ; Lefferts J; Gupta D; Steenbeek SC; van Rheenen J; El Andaloussi S; Schiffelers RM; Wood MJA; Vader P
- Article: METHODS IN MOLECULAR BIOLOGY. 2020;2109:35-44Sjöqvist S; Imafuku A; Gupta D; El Andaloussi S
- Article: INTERNATIONAL IMMUNOPHARMACOLOGY. 2020;78:106042Amin R; He R; Gupta D; Zheng W; Burmakin M; Mohammad DK; DePierre JW; Sadeghi B; Olauson H; Wernerson A; El-Andaloussi S; Hassan M; Abedi-Valugerdi M
- Article: PHARMACEUTICS. 2019;11(12):E666-666Saher O; Lehto T; Gissberg O; Gupta D; Gustafsson O; EL Andaloussi S; Darbre T; Lundin KE; Smith CIE; Zain R
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2019;8(1):1663043Corso G; Heusermann W; Trojer D; Goergens A; Steib E; Voshol J; Graff A; Genoud C; Lee Y; Hean J; Nordin JZ; Wiklander OPB; El Andaloussi S; Meisner-Kober N
- Article: ADVANCED FUNCTIONAL MATERIALS. 2019;29(48)Kuhn J; Klein PM; Al Danaf N; Nordin JZ; Reinhard S; Loy DM; Hoehn M; El Andaloussi S; Lamb DC; Wagner E; Aoki Y; Lehto T; Laechelt U
- Article: FRONTIERS IN NEUROSCIENCE. 2019;13:1067Lee YXF; Johansson H; Woody MJA; El Andaloussi S
- Article: NATURE COMMUNICATIONS. 2019;10(1):2331Ezzat K; Pernemalm M; Palsson S; Roberts TC; Jarver P; Dondalska A; Bestas B; Sobkowiak MJ; Levanen B; Skold M; Thompson EA; Saher O; Kari OK; Lajunen T; Ekstrom ES; Nilsson C; Ishchenko Y; Malm T; Wood MJA; Power UF; Masich S; Linden A; Sandberg JK; Lehtio J; Spetz A-L; EL Andaloussi S
- Article: ACS SENSORS. 2019;4(5):1399-1408Cavallaro S; Horak J; Haag P; Gupta D; Stiller C; Sahu SS; Gorgens A; Gatty HK; Viktorsson K; El Andaloussi S; Lewensohn R; Karlstrom AE; Linnros J; Dev A
- Article: DIABETES. 2019;68(3):515-526Katayama M; Wiklander OPB; Fritz T; Caidahl K; El-Andaloussi S; Zierath JR; Krook A
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2019;8(1):1587567Goergens A; Bremer M; Ferrer-Tur R; Murke F; Tertel T; Horn PA; Thalman S; Welsh JA; Probst C; Guerin C; Boulanger CM; Jones JC; Hanenber H; Erdbrugger U; Lannigan J; Ricklefs FL; El-Andaloussi S; Giebel B
- Article: METHODS IN MOLECULAR BIOLOGY. 2019;1953:287-299Nordin JZ; Bostancioglu RB; Corso G; El Andaloussi S
- Article: MOLECULAR THERAPY NUCLEIC ACIDS. 2018;13:1-15Coenen-Stass AML; Sork H; Gatto S; Godfrey C; Bhomra A; Krjutskov K; Hart JR; Westholm JO; O'Donovan L; Roos A; Lochmueller H; Puri PL; EL Andaloussi S; Wood MJA; Roberts TC
- Article: PROTEOMICS. 2018;18(24):e1800257Thompson AG; Gray E; Mager I; Fischer R; Thezenas M-L; Charles PD; Talbot K; El Andaloussi S; Kessler BM; Wood M; Turner MR
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2018;7(1):1535750Thery C; Witwer KW; Aikawa E; Jose Alcaraz M; Anderson JD; Andriantsitohaina R; Antoniou A; Arab T; Archer F; Atkin-Smith GK; Ayre DC; Bach J-M; Bachurski D; Baharvand H; Balaj L; Baldacchino S; Bauer NN; Baxter AA; Bebawy M; Beckham C; Zavec AB; Benmoussa A; Berardi AC; Bergese P; Bielska E; Blenkiron C; Bobis-Wozowicz S; Boilard E; Boireau W; Bongiovanni A; Borras FE; Bosch S; Boulanger CM; Breakefield X; Breglio AM; Brennan MA; Brigstock DR; Brisson A; Broekman MLD; Bromberg JF; Bryl-Gorecka P; Buch S; Buck AH; Burger D; Busatto S; Buschmann D; Bussolati B; Buzas EI; Byrd JB; Camussi G; Carter DRF; Caruso S; Chamley LW; Chang Y-T; Chen C; Chen S; Cheng L; Chin AR; Clayton A; Clerici SP; Cocks A; Cocucci E; Coffey RJ; Cordeiro-da-Silva A; Couch Y; Coumans FAW; Coyle B; Crescitelli R; Criado MF; D'Souza-Schorey C; Das S; Chaudhuri AD; de Candia P; De Santana Junior EF; De Wever O; del Portillo HA; Demaret T; Deville S; Devitt A; Dhondt B; Di Vizio D; Dieterich LC; Dolo V; Dominguez Rubio AP; Dominici M; Dourado MR; Driedonks TAP; Duarte FV; Duncan HM; Eichenberger RM; Ekstrom K; Andaloussi SEL; Elie-Caille C; Erdbrugger U; Falcon-Perez JM; Fatima F; Fish JE; Flores-Bellver M; Forsonits A; Frelet-Barrand A; Fricke F; Fuhrmann G; Gabrielsson S; Gamez-Valero A; Gardiner C; Gaertner K; Gaudin R; Gho YS; Giebel B; Gilbert C; Gimona M; Giusti I; Goberdhan DCI; Goergens A; Gorski SM; Greening DW; Gross JC; Gualerzi A; Gupta GN; Gustafson D; Handberg A; Haraszti RA; Harrison P; Hegyesi H; Hendrix A; Hill AF; Hochberg FH; Hoffmann KF; Holder B; Holthofer H; Hosseinkhani B; Hu G; Huang Y; Huber V; Hunt S; Ibrahim AG-E; Ikezu T; Inal JM; Isin M; Ivanova A; Jackson HK; Jacobsen S; Jay SM; Jayachandran M; Jenster G; Jiang L; Johnson SM; Jones JC; Jong A; Jovanovic-Talisman T; Jung S; Kalluri R; Kano S-I; Kaur S; Kawamura Y; Keller ET; Khamari D; Khomyakova E; Khvorova A; Kierulf P; Kim KP; Kislinger T; Klingeborn M; Klinke DJII; Kornek M; Kosanovic MM; Kovacs AF; Kraemer-Albers E-M; Krasemann S; Krause M; Kurochkin IV; Kusuma GD; Kuypers S; Laitinen S; Langevin SM; Languino LR; Lannigan J; Lasser C; Laurent LC; Lavieu G; Lazaro-Ibanez E; Le Lay S; Lee M-S; Lee YXF; Lemos DS; Lenassi M; Leszczynska A; Li ITS; Liao K; Libregts SF; Ligeti E; Lim R; Lim SK; Line A; Linnemannstoens K; Llorente A; Lombard CA; Lorenowicz MJ; Lorincz AM; Lotvall J; Lovett J; Lowry MC; Loyer X; Lu Q; Lukomska B; Lunavat TR; Maas SLN; Malhi H; Marcilla A; Mariani J; Mariscal J; Martens-Uzunova ES; Martin-Jaular L; Martinez MC; Martins VR; Mathieu M; Mathivanan S; Maugeri M; McGinnis LK; McVey MJ; Meckes DGJ; Meehan KL; Mertens I; Minciacchi VR; Moller A; Jorgensen MM; Morales-Kastresana A; Morhayim J; Mullier F; Muraca M; Musante L; Mussack V; Muth DC; Myburgh KH; Najrana T; Nawaz M; Nazarenko I; Nejsum P; Neri C; Neri T; Nieuwland R; Nimrichter L; Nolan JP; Nolte-'t Hoen ENM; Noren Hooten N; O'Driscoll L; O'Grady T; O'Loghlen A; Ochiya T; Olivier M; Ortiz A; Ortiz LA; Osteikoetxea X; Ostegaard O; Ostrowski M; Park J; Pegtel DM; Peinado H; Perut F; Pfaffl MW; Phinney DG; Pieters BCH; Pink RC; Pisetsky DS; von Strandmann EP; Polakovicova I; Poon IKH; Powell BH; Prada I; Pulliam L; Quesenberry P; Radeghieri A; Raffai RL; Raimondo S; Rak J; Ramirez MI; Raposo G; Rayyan MS; Regev-Rudzki N; Ricklefs FL; Robbins PD; Roberts DD; Rodrigues SC; Rohde E; Rome S; Rouschop KMA; Rughetti A; Russell AE; Saa P; Sahoo S; Salas-Huenuleo E; Sanchez C; Saugstad JA; Saul MJ; Schiffelers RM; Schneider R; Schoyen TH; Scott A; Shahaj E; Sharma S; Shatnyeva O; Shekari F; Shelke GV; Shetty AK; Shiba K; Siljander PR-M; Silva AM; Skowronek A; Snyder OLII; Soares RP; Sodar BW; Soekmadji C; Sotillo J; Stahl PD; Stoorvogel W; Stott SL; Strasser EF; Swift S; Tahara H; Tewari M; Timms K; Tiwari S; Tixeira R; Tkach M; Toh WS; Tomasini R; Torrecilhas AC; Pablo Tosar J; Toxavidis V; Urbanelli L; Vader P; van Balkom BWM; van der Grein SG; Van Deun J; van Herwijnen MJC; Van Keuren-Jensen K; van Niel G; van Royen ME; van Wijnen AJ; Helena Vasconcelos M; Vechetti IJJ; Veit TD; Vella LJ; Velot E; Verweij FJ; Vestad B; Vinas JL; Visnovitz T; Vukman KV; Wahlgren J; Watson DC; Wauben MHM; Weaver A; Webber JP; Weber V; Wehman AM; Weiss DJ; Welsh JA; Wendt S; Wheelock AM; Wiener Z; Witte L; Wolfram J; Xagorari A; Xander P; Xu J; Yan X; Yanez-Mo M; Yin H; Yuana Y; Zappulli V; Zarubova J; Zekas V; Zhang J-Y; Zhao Z; Zheng L; Zheutlin AR; Zickler AM; Zimmermann P; Zivkovic AM; Zocco D; Zuba-Surma EK
- Article: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2018;132:29-40Saher O; Rocha CSJ; Zaghioul EM; Wiklander OPB; Zamolo S; Heitz M; Ezzat K; Gupta D; Reymond J-L; Zain R; Hollfelder F; Darbre T; Lundin KE; El Andaloussi S; Smith CIE
- Article: SCIENTIFIC REPORTS. 2018;8(1):15841Jarver P; Dondalska A; Poux C; Sandberg A; Bergenstrahle J; Skold AE; Dereuddre-Bosquet N; Martinon F; Palsson S; Zaghloul E; Brodin D; Sander B; Lennox KA; Behlke MA; EL-Andaloussi S; Lehtio J; Lundeberg J; LeGrand R; Spetz A-L
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2018;504(4):749-752Translocation-generated ITK-FER and ITK-SYK fusions induce STAT3 phosphorylation and CD69 expressionFathi NN; Mohammad DK; Gorgens A; El Andaloussi S; Zain R; Nore BF; Smith CIE
- Article: SCIENTIFIC REPORTS. 2018;8(1):10813Sork H; Corso G; Krjutskov K; Johansson HJ; Nordin JZ; Wiklander OPB; Lee YXF; Westholm JO; Lehtio J; Wood MJA; Mager I; El Andaloussi S
- Article: FRONTIERS IN IMMUNOLOGY. 2018;9:1326Wiklander OPB; Bostancioglu RB; Welsh JA; Zickler AM; Murke F; Corso G; Felldin U; Hagey DW; Evertsson B; Liang X-M; Gustafsson MO; Mohammad DK; Wiek C; Hanenberg H; Bremer M; Gupta D; Bjornstedt M; Giebel B; Nordin JZ; Jones JC; EL Andaloussi S; Goergens A
- Journal article: NEUROMUSCULAR DISORDERS. 2017;27:s167-s168van Westering T; Johanson H; Coenen-Stass A; Miyatake S; Tanihata J; Takeda S; Yokota T; Lehtio J; Wood M; El Andaloussi S; Roberts T; Aoki Y
- Article: SCIENTIFIC REPORTS. 2017;7(1):11561Corso G; Mager I; Lee Y; Gorgens A; Bultema J; Giebel B; Wood MJA; Nordin JZ; Andaloussi SEL
- Article: BRAIN. 2017;140(4):887-897Aoki Y; Manzano R; Lee Y; Dafinca R; Aoki M; Douglas AGL; Varela MA; Sathyaprakash C; Scaber J; Barbagallo P; Vader P; Mager I; Ezzat K; Turner MR; Ito N; Gasco S; Ohbayashi N; El Andaloussi S; Takeda S; Fukuda M; Talbot K; Wood MJA
- Article: METHODS IN MOLECULAR BIOLOGY. 2017;1545:197-204Vader P; Mäger I; Lee Y; Nordin JZ; Andaloussi SEL; Wood MJA
- Journal article: CHINESE NEUROSURGICAL JOURNAL. 2016;2(1):36Anderson JD; Pham MT; Contreras Z; Hoon M; Fink KD; Johansson HJ; Rossignol J; Dunbar GL; Showalter M; Fiehn O; Bramlett CS; Bardini RL; Bauer G; Fury B; Hendrix KJ; Chedin F; EL-Andaloussi S; Hwang B; Mulligan MS; Lehtiö J; Nolta JA
- Article: NUCLEIC ACID THERAPEUTICS. 2016;26(6):381-391Rocha CSJ; Lundin KE; Behlke MA; Zain R; EL Andaloussi S; Smith CIE
- Article: HUMAN MOLECULAR GENETICS. 2016;25(18):3960-3974Coenen-Stass AML; Betts CA; Lee YF; Mager I; Turunen MP; El Andaloussi S; Morgan JE; Wood MJA; Roberts TC
- Article: DIABETOLOGIA. 2016;59(5):1049-1058Jalabert A; Vial G; Guay C; Wiklander OPB; Nordin JZ; Aswad H; Forterre A; Meugnier E; Pesenti S; Regazzi R; Danty-Berger E; Ducreux S; Vidal H; El-Andaloussi S; Rieusset J; Rome S
- Article: JOURNAL OF CELL BIOLOGY. 2016;213(2):173-184Heusermann W; Hean J; Trojer D; Steib E; von Bueren S; Graff-Meyer A; Genoud C; Martin K; Pizzato N; Voshol J; Morrissey DV; Andaloussi SEL; Wood MJ; Meisner-Kober NC
- Article: MOLECULAR THERAPY NUCLEIC ACIDS. 2016;5(3):e290Sork H; Nordin JZ; Turunen JJ; Wiklander OPB; Bestas B; Zaghloul EM; Margus H; Padari K; Duru AD; Corso G; Bost J; Vader P; Pooga M; Smith CIE; Wood MJA; Schiffelers RM; Hallbrink M; Andaloussi SEL
- Article: SCIENTIFIC REPORTS. 2016;6:22519Willms E; Johansson HJ; Mager I; Lee Y; Blomberg KEM; Sadik M; Alaarg A; Smith CIE; Lehtio J; Andaloussi SEL; Wood MJA; Vader P
- Article: GENOMICS DATA. 2016;7:88-89Roberts TC; Blomberg KEM; Smith CIE; El Andaloussi S; Wood MJA
- Article: STEM CELLS. 2016;34(3):601-613Anderson JD; Johansson HJ; Graham CS; Vesterlund M; Pham MT; Bramlett CS; Montgomery EN; Mellema MS; Bardini RL; Contreras Z; Hoon M; Bauer G; Fink KD; Fury B; Hendrix KJ; Chedin F; El-Andaloussi S; Hwang B; Mulligan MS; Lehtio J; Nolta JA
- Article: PLOS ONE. 2015;10(12):e0145686Baranyai T; Herczeg K; Onodi Z; Voszka I; Modos K; Marton N; Nagy G; Maeger I; Wood MJ; El Andaloussi S; Palinkas Z; Kumar V; Nagy P; Kittel A; Buzas EI; Ferdinandy P; Giricz Z
- Article: HUMAN MOLECULAR GENETICS. 2015;24(23):6756-6768Roberts TC; Johansson HJ; McClorey G; Godfrey C; Blomberg KEM; Coursindel T; Gait MJ; Smith CIE; Lehtio J; El Andaloussi S; Wood MJA
- Article: STEM CELLS TRANSLATIONAL MEDICINE. 2015;4(10):1199-1213Simonson OE; Mougiakakos D; Heldring N; Bassi G; Johansson HJ; Dalen M; Jitschin R; Rodin S; Corbascio M; El Andaloussi S; Wiklander OPB; Nordin JZ; Skog J; Romain C; Koestler T; Hellgren-Johansson L; Schiller P; Joachimsson P-O; Haegglund H; Mattsson M; Lentio J; Faridani OR; Sandberg R; Korsgren O; Krampera M; Weiss DJ; Grinnemo K-H; Le Blanc K
- Journal article: ZENTRALBLATT FUR CHIRURGIE. 2015;140(S 01)Jungebluth P; Holzgraefe B; Lim M; Duru A; Lundin V; Sjöqvist S; Jones P; Wood M; Luedde T; Teixeira A; Hermanson O; Winqvist O; Kalzén H; Nordin J; Wiklander O; EL Andaloussi S; Alici E; Dienemann H
- Article: HUMAN MOLECULAR GENETICS. 2015;24(15):4225-4237Godfrey C; Muses S; McClorey G; Wells KE; Coursindel T; Terry RL; Betts C; Hammond S; O'Donovan L; Hildyard J; El Andaloussi S; Gait MJ; Wood MJ; Wells DJ
- Article: NANO LETTERS. 2015;15(7):4364-4373Ezzat K; Aoki Y; Koo T; McClorey G; Benner L; Coenen-Stass A; O'Donovan L; Lehto T; Garcia-Guerra A; Nordin J; Saleh AF; Behlke M; Morris J; Goyenvalle A; Dugovic B; Leumann C; Gordon S; Gait MJ; El-Andaloussi S; Wood MJA
- Article: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2015;11(4):879-883Nordin JZ; Lee Y; Vader P; Maeger I; Johansson HJ; Heusermann W; Wiklander OPB; Hallbrink M; Seow Y; Bultema JJ; Gilthorpe J; Davies T; Fairchild PJ; Gabrielsson S; Meisner-Kober NC; Lehtio J; Smith CIE; Wood MJA; Andaloussi SEL
- Article: NUCLEIC ACID THERAPEUTICS. 2015;25(2):65-77Jarver P; Zaghloul EM; Arzumanov AA; Saleh AF; McClorey G; Hammond SM; Hallbrink M; Langel U; Smith CIE; Wood MJA; Gait MJ; EL Andaloussi S
- Article: NATURE MEDICINE. 2015;21(3):270-275Goyenvalle A; Griffith G; Babbs A; El Andaloussi S; Ezzat K; Avril A; Dugovic B; Chaussenot R; Ferry A; Voit T; Amthor H; Buehr C; Schuerch S; Wood MJA; Davies KE; Vaillend C; Leumann C; Garcia L
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2015;4:26316Wiklander OPB; Nordin JZ; O'Loughlin A; Gustafsson Y; Corso G; Maeger I; Vader P; Lee Y; Sork H; Seow Y; Heldring N; Alvarez-Erviti L; Smith CIE; Le Blanc K; Macchiarini P; Jungebluth P; Wood MJA; EL Andaloussi S
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2015;4:30087Lener T; Gimona M; Aigner L; Boerger V; Buzas E; Camussi G; Chaput N; Chatterjee D; Court FA; del Portillo HA; O'Driscoll L; Fais S; Falcon-Perez JM; Felderhoff-Mueser U; Fraile L; Gho YS; Goergens A; Gupta RC; Hendrix A; Hermann DM; Hill AF; Hochberg F; Horn PA; de Kleijn D; Kordelas L; Kramer BW; Kraemer-Albers E-M; Laner-Plamberger S; Laitinen S; Leonardi T; Lorenowicz MJ; Lim SK; Lotvall J; Maguire CA; Marcilla A; Nazarenko I; Ochiya T; Patel T; Pedersen S; Pocsfalvi G; Pluchino S; Quesenberry P; Reischl IG; Rivera FJ; Sanzenbacher R; Schallmoser K; Slaper-Cortenbach I; Strunk D; Tonn T; Vader P; van Balkom BWM; Wauben M; El Andaloussi S; Thery C; Rohde E; Giebel B
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2015;4:26883Li J; Lee Y; Johansson HJ; Maeger I; Vader P; Nordin JZ; Wiklander OPB; Lehtio J; Wood MJA; Andaloussi SEL
- Journal article: RESPIRATION. 2015;90(6):481-492Jungebluth P; Holzgraefe B; Lim ML; Duru AD; Lundin V; Heldring N; Wiklander OPB; Nordin JZ; Chrobok M; Roderburg C; Sjoqvist S; Anderstam B; Rodriguez AB; Haag JC; Gustafsson Y; Roddewig KG; Jones P; Wood MJA; Luedde T; Teixeira AI; Hermanson O; Winqvist O; Kalzen H; El Andaloussi S; Alici E; Macchiarini P
- Article: MOLECULAR THERAPY NUCLEIC ACIDS. 2014;3(11):e212Hammond SM; McClorey G; Nordin JZ; Godfrey C; Stenler S; Lennox KA; Smith CIE; Jacobi AM; Varela MA; Lee Y; Behlke MA; Wood MJA; Andaloussi SEL
- Article: MOVEMENT DISORDERS. 2014;29(12):1476-1485Cooper JM; Wiklander PBO; Nordin JZ; Al-Shawi R; Wood MJ; Vithlani M; Schapira AHV; Simons JP; El-Andaloussi S; Alvarez-Erviti L
- Article: DIABETOLOGIA. 2014;57(10):2155-2164Aswad H; Forterre A; Wiklander OPB; Vial G; Danty-Berger E; Jalabert A; Lamaziere A; Meugnier E; Pesenti S; Ott C; Chikh K; El-Andaloussi S; Vidal H; Lefai E; Rieusset J; Rome S
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2014;124(9):4067-4081Bestas B; Moreno PMD; Blomberg KEM; Mohammad DK; Saleh AF; Sutlu T; Nordin JZ; Guterstam P; Gustafsson MO; Kharazi S; Piatosa B; Roberts TC; Behlke MA; Wood MJA; Gait MJ; Lundin KE; El Andaloussi S; Mansson R; Berglof A; Wengel J; Smith CIE
- Article: MOLECULAR CANCER THERAPEUTICS. 2014;13(4):996-1007Hyvönen M; Enbäck J; Huhtala T; Lammi J; Sihto H; Weisell J; Joensuu H; Rosenthal-Aizman K; El-Andaloussi S; Langel U; Närvänen A; Bergers G; Laakkonen P
- Article: NUCLEIC ACID THERAPEUTICS. 2014;24(1):13-24Bestas B; McClorey G; Tedebark U; Moreno PMD; Roberts TC; Hammond SM; Smith CIE; Wood MJA; Andaloussi SEL
- Article: MOLECULAR THERAPY NUCLEIC ACIDS. 2014;3(1):e140Stenler S; Wiklander OPB; Badal-Tejedor M; Turunen J; Nordin JZ; Hallengard D; Wahren B; Andaloussi SEL; Rutland MW; Smith CIE; Lundin KE; Blomberg P
- Article: NATURE REVIEWS DRUG DISCOVERY. 2013;12(5):347-357EL Andaloussi S; Maeger I; Breakefield XO; Wood MJA
- Article: NUCLEIC ACIDS RESEARCH. 2013;41(5):3257-3273Moreno PMD; Geny S; Pabon YV; Bergquist H; Zaghloul EM; Rocha CSJ; Oprea II; Bestas B; El Andaloussi S; Jorgensen PT; Pedersen EB; Lundin KE; Zain R; Wengel J; Smith CIE
- Article: NATURE PROTOCOLS. 2012;7(12):2112-2126El-Andaloussi S; Lee Y; Lakhal-Littleton S; Li J; Seow Y; Gardiner C; Alvarez-Erviti L; Sargent IL; Wood MJA
- Article: HUMAN MOLECULAR GENETICS. 2012;21(R1):R125-R134Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapyLee Y; El Andaloussi S; Wood MJA
- Article: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 2012;22(17):5635-5638Viola JR; Stromberg R; Simonson OE; El Andaloussi S; Smith CIE; Murtola M
- Article: JOURNAL OF CONTROLLED RELEASE. 2012;162(1):1-8Ezzat K; Zaghloul EM; Andaloussi SEL; Lehto T; El-Sayed R; Magdy T; Smith CIE; Langel U
- Article: MOLECULAR THERAPY NUCLEIC ACIDS. 2012;1(8):e39Roberts TC; Blomberg KEM; McClorey G; Andaloussi SEL; Godfrey C; Betts C; Coursindel T; Gait MJ; Smith CIE; Wood MJA
- Article: MOLECULAR THERAPY NUCLEIC ACIDS. 2012;1(5):e23Roberts TC; Andaloussi SE; Morris KV; McClorey G; Wood MJ
- Article: FASEB JOURNAL. 2012;26(3):1172-1180Ezzat K; Helmfors H; Tudoran O; Juks C; Lindberg S; Padari K; El-Andaloussi S; Pooga M; Langel U
- Article: ISRN PHARMACEUTICS. 2012;2012:407154-7Muñoz-Alarcón A; Guterstam P; Romero C; Behlke MA; Lennox KA; Wengel J; El Andaloussi S; Langel U
- Article: NUCLEIC ACIDS RESEARCH. 2012;40(1):438-448Sibley CR; Seow Y; Saayman S; Dijkstra KK; El Andaloussi S; Weinberg MS; Wood MJA
- Article: MOLECULAR THERAPY. 2011;19(8):1457-1467Lehto T; Simonson OE; Mager I; Ezzat K; Sork H; Copolovici D-M; Viola JR; Zaghloul EM; Lundin P; Moreno PMD; Mae M; Oskolkov N; Suhorutsenko J; Smith CIE; Andaloussi SEL
- Article: JOURNAL OF CONTROLLED RELEASE. 2011;153(2):163-172Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
- Article: NUCLEIC ACIDS RESEARCH. 2011;39(12):5284-5298Ezzat K; EL Andaloussi S; Zaghloul EM; Lehto T; Lindberg S; Moreno PMD; Viola JR; Magdy T; Abdo R; Guterstam P; Sillard R; Hammond SM; Wood MJA; Arzumanov AA; Gait MJ; Smith CIE; Hallbrink M; Langel U
- Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2011;1808(6):1544-1551Holm T; Räägel H; Andaloussi SEL; Hein M; Mäe M; Pooga M; Langel Ü
- Article: VIROLOGY JOURNAL. 2011;8:243Viru L; Heller G; Lehto T; Paern K; El Andaloussi S; Langel U; Merits A
- Article: NUCLEIC ACIDS RESEARCH. 2011;39(9):3972-3987Andaloussi SEL; Lehto T; Maeger I; Rosenthal-Aizman K; Oprea II; Simonson OE; Sork H; Ezzat K; Copolovici DM; Kurrikoff K; Viola JR; Zaghloul EM; Sillard R; Johansson HJ; Hassane FS; Guterstam P; Suhorutsenko J; Moreno PMD; Oskolkov N; Haelldin J; Tedebark U; Metspalu A; Lebleu B; Lehtioe J; Smith CIE; Langel U
- Article: NUCLEIC ACIDS RESEARCH. 2011;39(3):1142-1154Zaghloul EM; Madsen AS; Moreno PMD; Oprea II; El-Andaloussi S; Bestas B; Gupta P; Pedersen EB; Lundin KE; Wengel J; Smith CIE
- Article: METHODS IN MOLECULAR BIOLOGY. 2011;764:75-89El Andaloussi S; Said Hassane F; Boisguerin P; Sillard R; Langel U; Lebleu B
- Article: EXPERT OPINION ON THERAPEUTIC PATENTS. 2011;21(1):115-119Lundin P; Moreno PMD; Smith CIE; Andaloussi SEL
- Article: METHODS IN MOLECULAR BIOLOGY. 2011;683:361-373Andaloussi SEL; Lehto T; Lundin P; Langel U
- Article: METHODS IN MOLECULAR BIOLOGY. 2011;683:219-230Guterstam P; Andaloussi SEL; Langel U
- Article: METHODS IN MOLECULAR BIOLOGY. 2011;683:195-205Lundin P; Andaloussi SEL; Langel U
- Article: BIOCONJUGATE CHEMISTRY. 2010;21(9):1662-1672Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
- Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2010;1798(3):338-343Mäger I; Eiríksdóttir E; Langel K; El Andaloussi S; Langel U
- Article: JOURNAL OF CONTROLLED RELEASE. 2010;141(1):42-51Lehto T; Abes R; Oskolkov N; Suhorutsenko J; Copolovici D-M; Mager I; Viola JR; Simonson OE; Ezzat K; Guterstam P; Eriste E; Smith CIE; Lebleu B; El Andaloussi S; Langel U
- Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2009;1788(12):2509-2517Guterstam P; Madani F; Hirose H; Takeuchi T; Futaki S; El Andaloussi S; Gräslund A; Langel U
- Article: JOURNAL OF CONTROLLED RELEASE. 2009;134(3):221-227Mae M; El Andaloussi S; Lundin P; Oskolkov N; Johansson HJ; Guterstam P; Langel U
- Article: INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS. 2009;15(1):11-15Mae M; Myrberg H; El-Andaloussi S; Langel U
- Article: BIOCONJUGATE CHEMISTRY. 2008;19(12):2535-2542Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; Andaloussi SEL
- Journal article: AIP CONFERENCE PROCEEDINGS. 2008;1062:73-88High-Throughput Identification of Combinatorial Ligands for DNA Delivery in Cell CultureSvahn MG; Rabe KS; Barger G; EL-Andaloussi S; Simonson OE; Didier B; Olivier R; Dumy P; Branden LJ; Niemeyer CM; Smith CIE
- Article: BIOCHEMICAL JOURNAL. 2008;412(2):307-313Guterstam P; Lindgren M; Johansson H; Tedebark U; Wengel J; El Andaloussi S; Langel U
- Article: INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS. 2008;14(1):58-63Jarver P; Fernaeus S; EL-Andaloussi S; Tjornhammar M-L; Langel U
- Article: MOLECULAR THERAPY. 2008;16(1):115-123Johansson HJ; El-Andaloussi S; Holm T; Maee M; Jaenes J; Maimets T; Langel U
- Article: MOLECULAR THERAPY. 2008;16(1):115-123Johansson HJ; El-Andaloussi S; Holm T; Mäe M; Jänes J; Maimets T; Langel U
- Article: BIOCHEMICAL JOURNAL. 2007;407(2):285-292El-Andaloussi S; Jarver P; Johansson HJ; Langel U
- Article: MOLECULAR THERAPY. 2007;15(10):1820-1826A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acidsEl-Andaloussi S; Johansson HJ; Holm T; Langel U
- Article: FASEB JOURNAL. 2007;21(11):2664-2671Lundberg P; El-Andaloussi S; Sutlu T; Johansson H; Langel U
- Article: BIOCHEMICAL SOCIETY TRANSACTIONS. 2007;35(Pt 4):770-774Järver P; Langel K; El-Andaloussi S; Langel U
- Article: NATURE PROTOCOLS. 2007;2(8):2043-2047El Andaloussi S; Guterstam P; Langel U
- Article: JOURNAL OF GENE MEDICINE. 2006;8(10):1262-1273El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
- Article: JOURNAL OF CONTROLLED RELEASE. 2005;110(1):189-201El-Andaloussi S; Johansson H; Magnusdottir A; Järver P; Lundberg P; Langel Ü
- Article: JOURNAL OF CONTROLLED RELEASE. 2005;103(2):511-523Kilk K; El-Andaloussi S; Järver P; Meikas A; Valkna A; Bartfai T; Kogerman P; Metsis M; Langel Ü
- Visa fler
Alla övriga publikationer
- Preprint: BIORXIV. 2025Tanriverdi S; Cruz J; Habibi S; Sych T; Costa M; Mårtensson G; Görgens A; Andaloussi SE; Brandt L; Tammisola O; Sezgin E; Russom A
- Book chapter: CANCER-TARGETED DRUG DELIVERY: METHODS IN PHARMACOLOGY AND TOXICOLOGY. 2025;p. 155-175Gustafsson O; EL Andaloussi S; Nordin JZ
- Book chapter: CANCER-TARGETED DRUG DELIVERY: METHODS IN PHARMACOLOGY AND TOXICOLOGY. 2025;p. 125-153Ilamathi HS; El Andaloussi S; Wiklander OPB
- Review: MOLECULAR ASPECTS OF MEDICINE. 2024;99:101302Payandeh Z; Tangruksa B; Synnergren J; Heydarkhan-Hagvall S; Nordin JZ; Andaloussi SEL; Boren J; Wiseman J; Bohlooly-Y M; Lindfors L; Valadi H
- Preprint: BIORXIV. 2024Kee N; Leboeuf M; Gómez S; Petitpré C; Mei I; Benlefki S; Hagey D; Dias J; Lallemend F; Andaloussi SE; Ericson J; Hedlund E
- Preprint: BIORXIV. 2024Garcia-Guerra A; Sathyaprakash C; de Jong OG; Lim WF; Vader P; Andaloussi SE; Bath J; Reine J; Aoki Y; Turberfield AJ; Wood MJA; Rinaldi C
- Preprint: BIORXIV. 2024Elsharkasy OM; Hegeman CV; Lansweers I; Cotugno OL; de Groot IY; de Wit ZEMNJ; Liang X; Garcia-Guerra A; Moorman NJA; Lefferts J; de Voogt WS; Gitz-Francois JJ; van Wesel ACW; Andaloussi SE; Schiffelers RM; Kooijmans SAA; Mastrobattista E; Vader P; de Jong OG
- Corrigendum: JOURNAL OF EXTRACELLULAR VESICLES. 2024;13(5)Zheng W; He R; Liang X; Roudi S; Bost J; Coly P-M; van Niel G; Andaloussi SEL
- Preprint: RESEARCH SQUARE. 2023Liang X; Gupta D; Xie J; Wonterghem E; Hoecke L; Hean J; Niu Z; Wiklander O; Zheng W; Wiklander R; He R; Mammad D; Bost J; Zhou G; Zhou H; Roudi S; Zickler A; Gorgens A; Hagey D; de Jong O; Uy A; Zong Y; Mager I; Perez C; Roberts T; Vader P; Fougerolles A; Wood M; Vandenbroucke R; Nordin J; El-Andaloussi S
- Preprint: RESEARCH SQUARE. 2023Lin L; Görgens A; Mussack V; Pepeldjiyska E; Hartz A; Aslan H; Rackl E; Rank A; Schmohl J; Krämer D; El-Andaloussi S; Pfaffl M; schmetzer H
- Conference publication: EUROPEAN BIOPHYSICS JOURNAL. 2023;52(SUPPL 1):S64Sych T; Schlegel J; Barriga H; Ojansivu M; Hanke L; Weber F; Bostancioglu B; Ezzat K; Stangl H; Plochberger B; Laurencikiene J; El Andaloussi S; Furth D; Stevens M; Sezgin E
- Review: MOLECULAR THERAPY. 2023;31(5):1231-1250Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loadingRadler J; Gupta D; Zickler A; EL Andaloussi S
- Preprint: BIORXIV. 2023Liang X; Gupta D; Xie J; Wonterghem EV; Hoecke LV; Hean J; Niu Z; Wiklander O; Zheng W; Wiklander RJ; He R; Mamand D; Bost J; Zhou G; Zhou H; Roudi S; Zickler AM; Gorgens A; Hagey D; de Jong O; Uy AG; Zong Y; Mager I; Perez CM; Roberts T; Vader P; Fougerolles AD; Wood M; Vandenbroucke R; Nordin J; EL Andaloussi S
- Conference publication: MOLECULAR THERAPY. 2023;31(4):730Radler JA; Corso G; Zickler AM; Kamei N; Zheng W; Gupta D; El-Andaloussi S
- Conference publication: MOLECULAR THERAPY. 2023;31(4):627Roudi S; El Andaloussi S; Gupta D
- Other: RESPIRATION. 2023;102(5):402-404Jungebluth P; Holzgraefe B; Lim ML; Duru AD; Lundin V; Heldring N; Wiklander OPB; Nordin JZ; Chrobok M; Roderburg C; Sjoqvist S; Anderstam B; Rodriguez AB; C. Haag J; Gustafsson Y; Roddewig KG; Jones P; Wood MJA; Luedde T; Teixeira AI; Hermanson O; Winqvist O; Kalzen H; El Andaloussi S; Alici E; Macchiarini P
- Conference publication: PEDIATRIC BLOOD & CANCER. 2023;70:S27Kvedaraite E; Milne P; Khalilnezhad A; Chevrier M; Lee HK; Hagey DW; Greenwood TVB; Lee NYS; Minnerup L; Yingrou T; Dutertre C-A; Benac N; Hwang YY; Lum J; Loh AHP; Teng KWW; Khalilnezhad S; Xu W; Resteu A; Liang TH; Guan NL; Larbi A; Howland SW; El Andaloussi S; Braier J; Rassidakis G; Galluzzo L; Dzionek A; Collin M; Henter J-I; Chen J; Ginhoux F
- Review: EXTRACELLULAR VESICLES AND CIRCULATING NUCLEIC ACIDS. 2023;4(2):170-190Gupta D; Wiklander OPB; Wood MJA; El-Andaloussi S
- Review: HANDBOOK OF CLINICAL NEUROLOGY. 2023;193:243-266Roudi S; Rädler JA; El Andaloussi S
- Review: HANDBOOK OF CLINICAL NEUROLOGY. 2023;193:227-241The promise and challenges of extracellular vesicles in the diagnosis of neurodegenerative diseases.Hagey DW; El Andaloussi S
- Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2022;142(12):S266Li C; Sun C; Elton JJ; Lohcharoenkal W; Gorgens A; El Andaloussi S; Sonkoly E; Pivarcsi A
- Conference publication: BLOOD. 2022;140:4463-4464He R; Zheng W; Rozing K; Li X; Yin Y; El Andaloussi S; Norgren S; Zhao Y; Hassan M
- Conference publication: CYTOTHERAPY. 2022;24(5):S94-S95Bost JP; Gupta D; El Andaloussi S; Saher O
- Conference publication: TISSUE ENGINEERING PART A. 2022;28:S250Bobbili MR; Schosserer M; Holnthoner W; Redl H; Gorgens A; EL Andaloussi S; Grillari J
- Corrigendum: NATURE COMMUNICATIONS. 2021;12(1):7357Dar GH; Mendes CC; Kuan W-L; Speciale AA; Conceicao M; Gorgens A; Uliyakina I; Lobo MJ; Lim WF; El Andaloussi S; Mager I; Roberts TC; Barker RA; Goberdhan DCI; Wilson C; Wood MJA
- Corrigendum: ACS NANO. 2021;15(11):18590-18591Bost JP; Barriga H; Holme MN; Gallud A; Maugeri M; Gupta D; Lehto T; Valadi H; Esbjorner EK; Stevens MM; El-Andaloussi S
- Review: ADVANCED DRUG DELIVERY REVIEWS. 2021;178:113961Gupta D; Zickler AM; El Andaloussi S
- Review: ACS NANO. 2021;15(9):13993-14021Bost JP; Barriga H; Holme MN; Gallud A; Maugeri M; Gupta D; Lehto T; Valadi H; Esbjorner EK; Stevens MM; El-Andaloussi S
- Review: NATURE METHODS. 2021;18(9):1013-1026Verweij FJ; Balaj L; Boulanger CM; Carter DRF; Compeer EB; D'Angelo G; El Andaloussi S; Goetz JG; Gross JC; Hyenne V; Kramer-Albers E-M; Lai CP; Loyer X; Marki A; Momma S; Nolte-'t Hoen ENM; Pegtel DM; Peinado H; Raposo G; Rilla K; Tahara H; Thery C; van Royen ME; Vandenbroucke RE; Wehman AM; Witwer K; Wu Z; Wubbolts R; van Niel G
- Conference publication: MOLECULAR THERAPY. 2021;29(4):220Liang X; Gupta D; Galli V; Zheng W; Davies C; Hean J; Kyriakopoulou E; Yang X; de Andres J; Mamand DR; Amin R; Niu Z; Jawad R; Wiklander O; Zickler A; Gustafsson M; Gorgens A; Nordin JZ; EL Andaloussi S
- Corrigendum: NATURE COMMUNICATIONS. 2020;11(1):1701de Jong OG; Murphy DE; Mager I; Willms E; Garcia-Guerra A; Gitz-Francois JJ; Lefferts J; Gupta D; Steenbeek SC; van Rheenen J; El Andaloussi S; Schiffelers RM; Wood MJA; Vader P
- Preprint: BIORXIV. 2020Dar GH; Mendes CC; Kuan W-L; Conceição M; El-Andaloussi S; Mager I; Roberts TC; Barker RA; Goberdhan DCI; Wilson C; Wood MJA
- Corrigendum: METHODS IN MOLECULAR BIOLOGY. 2020;2109:293Sjöqvist S; Imafuku A; Gupta D; El Andaloussi S
- Editorial comment: NATURE BIOMEDICAL ENGINEERING. 2020;4(1):9-11Zickler AM; Andaloussi SEL
- Review: ADVANCED DRUG DELIVERY REVIEWS. 2020;159:332-343Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; EL Andaloussi S; Vader P
- Review: SCIENCE TRANSLATIONAL MEDICINE. 2019;11(492):eaav8521Wiklander OPB; Brennan MA; Lotval J; Breakefield XO; EL Andaloussi S
- Corrigendum: BRAIN. 2018;141(5):e42Aoki Y; Manzano R; Lee Y; Dafinca R; Aoki M; Douglas AGL; Varela MA; Sathyaprakash C; Scaber J; Barbagallo P; Vader P; Mager I; Ezzat K; Turner MR; Ito N; Gasco S; Ohbayashi N; El Andaloussi S; Takeda S; Fukuda M; Talbot K; Wood MJA
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):290Jarver P; Dondalska A; Skold A; Sandberg A; Zaghloul E; Brodin D; Poux C; Lehtio J; Lennox K; Behlke M; Le Grand R; El-Andaloussi S; Spetz A-L
- Published conference paper: MOLECULAR THERAPY. 2017;25(7):1580-1587O'Loughlin AJ; Mager I; de Jong OG; Varela MA; Schiffelers RM; El Andaloussi S; Wood MJA; Vader P
- Review: CIRCULATION RESEARCH. 2017;120(10):1632-1648Coumans FAW; Brisson AR; Buzas EI; Dignat-George F; Drees EEE; El-Andaloussi S; Emanueli C; Gasecka A; Hendrix A; Hill AF; Lacroix R; Lee Y; van Leeuwen TG; Mackman N; Maeger I; Nolan JP; van der Pol E; Pegtel DM; Sahoo S; Siljander PRM; Sturk G; de Wever O; Nieuwland R
- Conference publication: MOLECULAR THERAPY. 2017;25(5):121-122Aoki Y; Rocha C; Miyatake S; Takeda S; Wood M; El Andaloussi S
- Conference publication: MOLECULAR THERAPY. 2017;25(5):36Gupta D; Turunen J; Gait MJ; Wood M; El Andaloussi S
- Conference publication: CELL TRANSPLANTATION. 2017;26:704Anderson JD; Rossignol J; Dunbar GL; Yavagal D; EL-Andaloussi S; Lehtio J; Nolta JA
- Review: EMBO MOLECULAR MEDICINE. 2017;9(5):545-557Godfrey C; Desviat LR; Smedsrod B; Pietri-Rouxel F; Denti MA; Disterer P; Lorain S; Nogales-Gadea G; Sardone V; Anwar R; El Andaloussi S; Lehto T; Khoo B; Brolin C; van Roon-Mom WMC; Goyenvalle A; Aartsma-Rus A; Arechavala-Gomeza V
- Conference publication: NEUROMUSCULAR DISORDERS. 2017;27:S31-S32Manzano R; Aoki Y; Lee Y; Nca RD; Aoki M; Douglas AGL; Varela MA; Sathyaprakash C; Scaber J; Barbagallo P; Vader P; Mager I; Ezzat K; Turner MR; Ito N; Gasco S; Ohbayashi N; El Andaloussi S; Taked S; Fukuda M; Talbot K; Wood MJA
- Conference publication: NEUROMUSCULAR DISORDERS. 2017;27:S5-S6van Westering TLE; Johansson HJ; Coenen-Stass AML; Tanihata J; Takeda S; Yokota T; Lehtio J; Wood MJA; El Andaloussi S; Roberts TC; Aoki Y
- Conference publication: CELL TRANSPLANTATION. 2017;26(4):704Anderson JD; Rossignol J; Dunbar GL; Yavagal D; EL-Andaloussi S; Lehtio J; Nolta JA
- Review: ADVANCED DRUG DELIVERY REVIEWS. 2016;106(Pt A):172-182Lehto T; Ezzat K; Wood MJA; EL Andaloussi S
- Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:1084Jarver P; Dondalska A; Lennox K; Behlke M; EL-Andaloussi S; Spetz A-L
- Corrigendum: STEM CELLS TRANSLATIONAL MEDICINE. 2016;5(6):845Simonson OE; Mougiakakos D; Heldring N; Bassi G; Johansson HJ; Dalen M; Jitschin R; Rodin S; Corbascio M; El Andaloussi S; Wiklander OPB; Nordin JZ; Skog J; Romain C; Koestler T; Hellgren-Johansson L; Schiller P; Joachimsson P-O; Hagglund H; Mattsson M; Lehtio J; Faridani OR; Sandberg R; Korsgren O; Krampera M; Weiss DJ; Grinnemo K-H; Le Blanc K
- Review: NATURE REVIEWS NEUROLOGY. 2016;12(6):346-357Thompson AG; Gray E; Heman-Ackah SM; Mager I; Talbot K; El Andaloussi S; Wood MJ; Turner MR
- Editorial comment: ACS NANO. 2016;10(4):3886-3899Fais S; O'Driscoll L; Borras FE; Buzas E; Camussi G; Cappello F; Carvalho J; da Silva AC; Del Portillo H; El Andaloussi S; Trcek TF; Furlan R; Hendrix A; Gursel I; Kralj-Iglic V; Kaeffer B; Kosanovic M; Lekka ME; Lipps G; Logozzi M; Marcilla A; Sammar M; Llorente A; Nazarenko I; Oliveira C; Pocsfalvi G; Rajendran L; Raposo G; Rohde E; Siljander P; van Niel G; Vasconcelos MH; Yanez-Mo M; Yliperttula ML; Zarovni N; Zavec AB; Giebel B
- Conference publication: CELL TRANSPLANTATION. 2016;25(4):750Proteomic and Therapeutic Profile of Mesenchymal Stem Cell Exosomes in Neurological-Related DiseasesAnderson JD; Rossignol J; Lein P; EL-Andaloussi S; Lehtio J; Nolta JA
- Review: METHODS IN MOLECULAR BIOLOGY. 2016;1364:291-310Roberts TC; Ezzat K; El Andaloussi S; Weinberg MS
- Conference publication: NEUROMUSCULAR DISORDERS. 2015;25:S312-S313Muses S; Godfrey C; McClorey G; Wells K; Coursindel T; Terry R; Betts C; Cappellari O; Hammond S; O'Donovan E; Hildyard J; El Andaloussi S; Gait M; Wood M; Wells D
- Review: HUMAN GENE THERAPY. 2015;26(8):506-517Heldring N; Mager I; Wood MJA; Le Blanc K; Andaloussi SEL
- Review: CURRENT ALLERGY AND ASTHMA REPORTS. 2015;15(3):510Bestas B; Turunen JJ; Blomberg KEM; Wang Q; Mansson R; Andaloussi SEL; Berglof A; Smith CIE
- Conference publication: JOURNAL OF CLINICAL IMMUNOLOGY. 2014;34:S152Smith CIE; Bestas B; Moreno PMD; Berglof B; Blomberg KEM; Mohammad DK; Saleh AF; Sutlu T; Lundin KE; Nordin JZ; Kharazi S; Manson R; EL Andaloussi S; Gait MJ; Wengel J
- Editorial comment: MOLECULAR THERAPY. 2014;22(3):485-486Mager I; Roberts TC; Wood MJA; Andaloussi SEL
- Review: ADVANCED DRUG DELIVERY REVIEWS. 2013;65(3):391-397El Andaloussi S; Lakhal S; Mäger I; Wood MJA
- Conference publication: JOURNAL OF CLINICAL IMMUNOLOGY. 2012;32:165-166Bestas B; Moreno PM; Blomberg KEM; Berglof A; Gustafsson MO; Mohammad DK; Sutlu T; Lundin KE; Asplund AC; El-Andaloussi S; Gait MJ; Wengel J; Smith CIE
- Review: MOLECULAR THERAPY NUCLEIC ACIDS. 2012;1(6):e27Järver P; Coursindel T; Andaloussi SE; Godfrey C; Wood MJ; Gait MJ
- Review: CURRENT GENE THERAPY. 2012;12(3):161-178El Andaloussi SA; Hammond SM; Mäger I; Wood MJA
- Editorial comment: MOLECULAR THERAPY NUCLEIC ACIDS. 2012;1(5):e24Varela MA; Roberts TC; Andaloussi SE; Wood MJ
- Review: METHODS IN MOLECULAR BIOLOGY. 2011;683:207-217Holm T; Andaloussi SEL; Langel U
- Review: METHODS IN MOLECULAR BIOLOGY. 2011;683:233-247Johansson HJ; Andaloussi SEL; Langel U
- Review: EXPERT OPINION ON DRUG DELIVERY. 2010;7(6):721-735Viola JR; El-Andaloussi S; Oprea II; Smith CIE
- Review: CURRENT PHARMACEUTICAL DESIGN. 2010;16(9):1167-1178Ezzat K; El Andaloussi S; Abdo R; Langel U
- Review: EXPERT OPINION ON DRUG DELIVERY. 2009;6(11):1195-1205Mae M; El Andaloussi S; Lehto T; Langel U
- Book chapter: HANDBOOK OF CELL-PENETRATING PEPTIDES, SECOND EDITION: PHARMACOLOGY AND TOXICOLOGY: BASIC AND CLINICAL ASPECTS. 2006;p. 375-386El-Andaloussi S; Johansson H; Lundberg P; Langel U
- Review: CURRENT PHARMACEUTICAL DESIGN. 2005;11(28):3597-3611El-Andaloussi S; Holm T; Langel U
- Visa fler
Forskningsbidrag
- Swedish Research Council1 January 2025 - 31 December 2029To date, there are no curative treatments for most neurodegenerative disorders, including synucleinopathies of the central nervous system (CNS) such as Parkinsons disease (PD). The greatest challenges in treating these are currently insufficient penetration of drugs to the parenchyma of the brain and achieving stable reduction of α-synuclein (SNCA) protein aggregation, the most significant hallmark of PD pathology. Therefore, it is imperative to find new solutions to these unmet medical needs. Recently, we have harnessed nature’s own nanoparticles, extracellular vesicles (EVs), for targeted delivery of biotherpeutics, with focus on Cas9-based gene editors. Here, we will establish a novel CNS delivery platform exploiting these engineered EVs for CRISPR/Cas9-mediated silencing of SNCA gene expression and prevention of α-synuclein aggregation. After optimization of EV engineering components focusing on enhanced cargo loading, gene editing, and EV delivery to deep brain parenchyma, we will demonstrate their therapeutic effect in models of PD by local injection into the brain of mice using osmotic pumps. If successful, this will open an entirely new avenue to treat PD and other synucleinopathies. Importantly, the modular nature of the EV engineering platform permits further adaptation to deliver other gene editors or drug modalities, thereby opening innovative possibilities to treat a range of CNS diseases.
- Medical Research Council1 January 2025 - 31 December 2031Genome-targeted therapies, e.g., CRISPR-Cas9, use genetic sequence to target their actions to specific genes, bringing unrivalled specificity. This specificity will revolutionise healthcare, bringing therapies to previously untreatable rare disorders and precision gene- and cell-specific approaches to common disorders. By simply modifying the target sequence, a therapy can be retargeted to treat a new disorder. Our challenge is to unlock this potential, by developing 'Therapeutic Genomics' (TG), a genome-led, patient-centred, data-driven vision to bring genome-targeted therapies to the clinic, at scale. To achieve this challenge, our research aims to answer five major questions. First, which variants and which patients can be treated? We will develop computational and experimental methods to identify tractable genetic variants with different genome-targeted therapies. Applying these to genome sequencing data collected nationwide by researchers and the NHS, we will identify patients with correctable variants and symptoms appropriate to experimental therapies. Second, how can Therapeutic Platforms be developed and retargeted at scale to treat numerous genetic disorders? In collaboration with the laboratory that discovered CRISPR-Cas9 (UC Berkeley), we will develop exemplar Therapeutic Platforms and then retarget these to develop numerous therapies for other variants and disorders. Working with our industry partners, including Intellia and Danaher, we will develop high-throughput parallelized methods for measuring potency and safety in scalable cellular models, reducing the reliance on animal testing. Subsequent generations of Therapeutic Platforms and retargeting will extend therapies to more disorders. Third, how can Therapeutic Platform therapies be delivered effectively? At present, we lack a suitable vector for targeting neurons throughout the brain, a hurdle complicated by the inaccessibility of mature human neurons. Using cutting-edge technology to maintain human neuronal viability post-mortem, we will use directed evolution to develop brain-wide and cell-type-specific delivery systems, including viral, non-viral, and hybrid approaches. Fourth, how can insights from one therapy be used to improve the next therapy? By collecting data throughout our CoRE's research, we will apply artificial intelligence to refine our therapeutic and delivery technologies, ultimately developing safer and more effective therapies that treat an ever-expanding list of disorders. The data and algorithms from this work will be shared publicly to help design suitable therapies for all patients who need them. Fifth, how can we foster the research culture and clinical ecosystem to bring therapies to the clinic? Our research aims can only be achieved through a positive, inclusive research culture (e.g., openness, collaboration, teamwork, integrity, and diversity), and an interdisciplinary team. The MRC CoRE in TG will build on institutional initiatives to support culture change, embracing opportunities to enhance mentorship, teamwork, and communication. Key principles of Equality, Diversity, and Inclusion (EDI) and inclusive Public Patient Involvement and Engagement (PPIE) will be fully integrated into, and will enrich, the planning and execution of the CoRE's activities and governance. The MRC CoRE in TG will prime the clinical landscape required to bring genome-targeted therapies to the clinic, in collaboration with stakeholders and patients. Our team has the experience and facilities to secure additional funding and conduct first-in-human clinical trials. We will enlist UK infrastructure and industrial collaboration to reduce manufacturing costs and engage with the UK and other regulatory agencies to define workable standards for assessing Therapeutic Platforms. By developing urgently needed therapies for multiple rare disorders today, we will develop the expertise and capacity to better treat all rare and common disorders in the future.
- Ming Wai Lau Centre for Reparative Medicine (MWLC)1 January 2024 - 31 December 2026
- VINNOVA29 September 2023 - 30 June 2024
- Platform development of innovative bioconjugates for cardiac delivery of antisense oligonucleotidesNovo Nordisk Foundation (NNF)1 August 2023 - 1 August 2026
- Knut och Alice Wallenberg Stiftelse (KAW)1 July 2023 - 31 December 2028
- Förvandling av tillförsel, säkerhet och effekt av nukleinsyraterapi: från intracellulärt upptag till inriktning på hjärna och musklerMedical Research Council1 November 2022 - 31 October 2025
- UK Research and Innovation1 November 2022 - 31 October 2025Nucleic acid therapies (NATs) are genetic medicines that address the root cause of disease and have the potential to transform healthcare and provide life changing solutions for numerous areas of unmet need. Neurological, neuromuscular and cardiovascular diseases in particular devastate lives and create a very significant economic and social burden across the entire global population. While NATs have begun to be a reality over the last decade with multiple medicines being approved for use in the US and Europe many challenges remain particularly for diseases outside the liver and for those not easily addressed by local drug delivery solutions. Moreover, recent clinical trial results indicate that safety considerations should be addressed in parallel with the development of delivery solutions. The challenge of NAT delivery put simply is to deliver the drug effectively across the cell membrane into the appropriate sub-cellular compartment at a sufficient concentration required for activity in the absence of significant safety signals - so called 'productive' delivery. Our proposed solution is therefore to understand the requirements for productive delivery of NATs and to exploit this knowledge base for the development of NAT conjugates - our technical solution. Building on extensive experience of our consortium of academic and industry scientists, we will take two independent approaches to NAT conjugates, where delivery agents are directly chemically attached to the NAT drug. First, we will study and optimise lipid conjugates, where a range of lipid entities are directly attached to the NAT via a series of chemical linkers with different properties. In the first instance the NAT is one targeting a common gene of no therapeutic relevance. Our second approach of high potential will be to study and optimise antibody conjugates, where an antibody (or antibody fragment or antibody derived peptide) that binds to a specific cell membrane ligand is conjugated chemically again via chemical linkers. In each case, we will have starting points with conjugates that have already emerged through the work of consortium members, and in the case of antibodies we will have two independent approaches for identifying and prioritising new ligands for antibody targeting, again building on pre-existing work in the consortium. Our extensive chemistry capabilities will generate conjugate materials and control compounds for study and first step of which will be extensive in vitro studies in cells to develop mechanism-based knowledge on productive cell uptake allowing us to select lead compounds for more detailed study based on cell uptake/efficacy/safety properties, and to iterate compound structure and chemistry based on new knowledge, know-how and data generated. Further study will comprise translational studies in ex vivo human model systems based on human cells and stem cells and also based on human three dimensional organ like systems that provide cell diversity and architectural arrangements more closely mimicking human tissues. Further translational studies in established and new rodent models will allow delivery to cells and tissues of brain, heart and muscle to be studied in detail at singe cell resolution permitting cell/tissue biodistribution to be correlated with efficacy and safety measures. Finally, a small number of lead NAT compounds will be studied in disease models related to Huntington's disease and muscular dystrophy. We will maximise the potential of data by analysing and integrating across the programme and implementing machine-learning approaches to exploit our data. We will deliver fundamental knowledge, know-how, data and IP on productive uptake and novel lipid/antibody NATs of high therapeutic potential for further study. We will also engage the broader NAT community via reports/meetings/conferences and develop training opportunities, all of the above working in close collaboration with the NATA Hub. Technical Summary CNS and neuromuscular diseases devastate lives and create vast global economic costs (>$817Bn in 2021). Nucleic acid therapeutics (NAT) have huge potential to treat such disorders by addressing the disease cause. Despite recent advances, significant challenges in NAT delivery to many cell/tissue types remain. Recent clinical trials have identified toxicity issues, emphasising the need to consider safety in parallel with efforts to improve delivery. Our aim is to achieve productive, safe NAT delivery, leading to the intended activity, and this can only be accomplished by advancing mechanism-based understanding and developing NAT bioconjugates that address the technical demands. Here we establish a world-leading consortium to address the NAT delivery challenge, advancing the study of improved NAT compounds to understand the mechanistic basis of productive NAT uptake and its implications for intracellular/in vivo delivery, trafficking, safety, and delivery to CNS, heart, and muscle. We will develop and study a range of next-generation NAT compounds (focussing on lipid and antibody/peptide bioconjugates) to be evaluated as follows: 1 Mechanistic in vitro studies of cell uptake, endosomal escape, compartment (cytoplasm/nucleus/mitochondria) localisation - quantifying productive cell uptake, distribution, safety and efficacy readouts. 2 Development of novel ex vivo human tissue organoid models to screen and evaluate cell/tissue delivery, safety, and efficacy. 3 Translational in vivo studies in wild-type and novel reporter rodent species to investigate CNS and heart/muscle delivery, using available consortium tool compounds against reporter/other targets e.g. MALAT1 and quantifying distribution and efficacy at single cell resolution. 4 Selection of lead NAT compounds to study in clinically relevant disease models e.g. HD and DMD. 5 All data will be analysed and integrated computationally to allow machine-learning-based advances in NAT development to be made.
- Cancerfonden1 January 2022 - 31 December 2024
- EU-projekt DELIVER, Grant Agreement number 101001374Europeiska forskningsrådet1 March 2021 - 28 February 2026
- European Research Council1 March 2021 - 28 February 2026Nucleic acid-based medicines have opened a new avenue in drug discovery to target currently undruggable genes and to express therapeutic proteins, unlocking novel therapeutic options for a range of diseases, including neurodegeneration. However, they need to be encapsulated in nanocarriers to ensure their stability and efficient uptake into cells and tissues. Synthetic nanoparticles based on cell-penetrating peptides (CPPs) and, particularly, lipid nanoparticles (LNPs) have recently emerged as potent vectors for hepatic delivery. However, these systems fail to robustly target other organs in a safe manner. Another promising nanocarrier for advanced drug delivery is extracellular vesicles (EVs) that have the ability to efficiently convey macromolecules into cells. As native nanoparticles, EVs benefit from immune tolerance as well as the ability to cross biological barriers to reach, for example, the brain. We have developed advanced strategies to bioengineer cells to generate EVs loaded with therapeutic RNAs and proteins. However, their production at scale is cumbersome and time consuming. Here, I propose a platform development using synthetic nanocarriers to transiently engineer hepatic cells in vivo and harness EVs to functionally DELIVER biotherapeutics to currently unreachable, distant organs, focusing on brain. To achieve this, genetic constructs will be developed that allow for transient in situ engineering of cells in vivo and release of cargo (e.g. CRE)- laden EVs, displaying CNS-specific peptides, that can be functionally transported to distant organs, including brain. We will exploit the same strategy using CPP-based nanoformulations, recently developed in my lab, injected locally in brain to secrete EVs loaded with the disease-relevant protein GBA1 as a treatment strategy for Parkinson´s disease. Long-term this novel project has enormous potential, as any engineered EV could be produced in situ and be used for delivery of virtually any biotherapeutics.
- Utveckling av modifierade extracellulära vesiklar för riktad leverans av RNA terapiVetenskapsrådet (VR)1 January 2021 - 31 December 2025
- Swedish Research Council1 January 2021 - 31 December 2024
- US Army1 September 2020 - 31 March 2024
- Muscle-Targeted Cell-Penetrating Peptides for Delivery of Cas9-RNPs and Modified mRNA to Dystrophic MuscleCongressionally Directed Medical Research Programs1 September 2020 - 31 August 2023
- Europeiska kommissionen1 September 2019 - 28 February 2025
- Stiftelsen för Strategisk Forskning (SSF)12 September 2017 - 31 December 2024
- Swedish Research Council1 January 2016 - 31 December 2019
- Biotechnology and Biological Sciences Research Council30 September 2015 - 31 March 2019
- Medical Research Council31 August 2015 - 29 April 2021
- Financing of Swedish sub-project within the project GlioEx. Call 2013 in the ERA-Net EuroNanoMed II.Swedish Research Council1 January 2014 - 31 December 2016
- Visa fler
Anställningar
- Professor, Laboratoriemedicin, Karolinska Institutet, 2021-
Examina och utbildning
- Docent, Molekylär medicin, Karolinska Institutet, 2018
- Disputerade, Stockholm University, 2008
- Examen i molekylär cellbiologi, Södertörn University, 2002
Gästforskning och resestipendier
- Research fellow University of Oxford, University of Oxford, 2013-2018
- Postdocs, University of Oxford, 2011-2013
- Postdocs KI:s institution för laboratoriemedicin, Karolinska Institutet, 2010-2012
- Postdocs vid Stockholms universitet 2008–2010, Stockholm University, 2008-2010